- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 527M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 249M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $7.7B |
| Capex restated | Q1 2026 · Mar 31, 2025 | $1.41B |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $2.98B |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $61M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $17.31B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $14.67B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $7.55B |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $6.71B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $2.24B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $3.13B |
| Cash And Equivalents restated | Q1 2026 · Mar 31, 2025 | $1.28B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $4.76B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $3.34B |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $1.91B |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | −$414M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $17.82B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $16.44B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $50.81B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $45.97B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $5.61B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $7.49B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $55.57B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $49.3B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.40 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$1.49 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.40 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$1.40 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $164M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $175M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $104M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $70M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$740M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$315M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$144M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$27M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $716M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $262M |
| Revenue | Q1 2026 · Mar 31, 2026 | $2.08B |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $982M |